245 related articles for article (PubMed ID: 11025592)
1. Cytotoxic hepatosplenic gammadelta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biologic and clinical features.
Weidmann E; Hinz T; Klein S; Schui DK; Harder S; Kriener S; Kabelitz D; Hoelzer D; Mitrou PS
Haematologica; 2000 Oct; 85(10):1024-31. PubMed ID: 11025592
[TBL] [Abstract][Full Text] [Related]
2. Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.
Niitsu N; Kohri M; Togano T; Nakamine H; Nakamura S; Iwabuchi K; Higashihara M
Eur J Haematol; 2004 Nov; 73(5):367-71. PubMed ID: 15458516
[TBL] [Abstract][Full Text] [Related]
3. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic gamma-delta T-cell lymphoma as a late-onset posttransplant lymphoproliferative disorder in renal transplant recipients.
Wu H; Wasik MA; Przybylski G; Finan J; Haynes B; Moore H; Leonard DG; Montone KT; Naji A; Nowell PC; Kamoun M; Tomaszewski JE; Salhany KE
Am J Clin Pathol; 2000 Apr; 113(4):487-96. PubMed ID: 10761449
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
[TBL] [Abstract][Full Text] [Related]
6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemia.
Camera A; Pezzullo L; Villa MR; Luciano L; Pane F; Izzo B; Boccuni P; Di Noto R; Del Vecchio L; Salvatore F; Rotoli B
Haematologica; 2000 May; 85(5):496-501. PubMed ID: 10800166
[TBL] [Abstract][Full Text] [Related]
8. Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.
Gopcsa L; Bányai A; Tamáska J; Karádi A; Matolcsy A; Pálóczi K
Haematologia (Budap); 2002; 32(4):519-27. PubMed ID: 12803128
[TBL] [Abstract][Full Text] [Related]
9. TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.
Dolstra H; Fredrix H; van der Meer A; de Witte T; Figdor C; van de Wiel-van Kemenade E
Bone Marrow Transplant; 2001 May; 27(10):1087-93. PubMed ID: 11438826
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
[TBL] [Abstract][Full Text] [Related]
11. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
12. [Hepatosplenic gammadeltaT-cell lymphoma: a clinicopathological study].
Geng J; Zhu MG; Ding YQ; Han HX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):88-90. PubMed ID: 14724108
[TBL] [Abstract][Full Text] [Related]
13. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature.
Khan WA; Yu L; Eisenbrey AB; Crisan D; al Saadi A; Davis BH; Hankin RC; Mattson JC
Am J Clin Pathol; 2001 Jul; 116(1):41-50. PubMed ID: 11447750
[TBL] [Abstract][Full Text] [Related]
14. The first infant case with hepatosplenic gammadelta T-cell lymphoma after acute disseminated encephalomyelitis (ADEM)-like exacerbation.
Koga SY; Kumaki S; Ichinohasama R; Munakata M; Haginoya K; Ohashi Y; Tanaka Y; Sakamoto O; Minegishi M; Morio T; Iinuma K; Tsuchiya S
J Pediatr Hematol Oncol; 2006 Nov; 28(11):741-5. PubMed ID: 17114961
[TBL] [Abstract][Full Text] [Related]
15. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment.
Procházka V; Papajík T; Jarosová M; Pikalová Z; Indrák K; Tichý M; Kucerová L; Fakan F; Bílý M; Starostka D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):275-6. PubMed ID: 16601770
[TBL] [Abstract][Full Text] [Related]
16. Gamma/delta T-cell lymphoma with hepatosplenomegaly: report of a case.
Ohno T; Komada F; Yamaguchi M; Oka K; Nishii K; Tsuda M; Katsuta K; Yamaguchi T; Kita K; Shirakawa S
Int J Hematol; 1993 Jun; 57(3):269-76. PubMed ID: 8364190
[TBL] [Abstract][Full Text] [Related]
17. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
18. Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
Dictor M; Warenholt J; Isinger A
Haematologica; 2005 Nov; 90(11):1524-32. PubMed ID: 16266900
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A
Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635
[TBL] [Abstract][Full Text] [Related]
20. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]